Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

Clinical trial NCT07524530 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07524530
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Core Binding Factor Alpha Subunits Hematologic Neoplasms Leukemia Lymphoma

Start date: 2026-08-23
Primary completion: 2033-06-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.